200,000+ products from a single source!
sales@angenechem.com
CAS No: 1613-32-7 Catalog No: AG001SBC MDL No:
Title | Journal |
---|---|
Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model. | Parasite (Paris, France) 20111101 |
Structures, targets and recent approaches in anti-leishmanial drug discovery and development. | The open medicinal chemistry journal 20110101 |
Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20081201 |
Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. | Bioorganic & medicinal chemistry 20031117 |
Determination of the human cytochrome P450s involved in the metabolism of 2n-propylquinoline. | Xenobiotica; the fate of foreign compounds in biological systems 20030401 |
Decrease of intestinal P-glycoprotein activity by 2n-propylquinoline, a new oral treatment for visceral leishmaniasis. | Experimental parasitology 20030101 |
Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline. | Phytotherapy research : PTR 20011101 |
© 2019 Angene International Limited. All rights Reserved.